Copyright Reports & Markets. All rights reserved.

Global Embolotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Embolotherapy by Type
    • 1.3.1 Overview: Global Embolotherapy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Embolotherapy Consumption Value Market Share by Type in 2023
    • 1.3.3 Microspheres for Embolization
    • 1.3.4 Embolism Particles
    • 1.3.5 Embolic coils
    • 1.3.6 Liquid Embolic Agent
    • 1.3.7 Auxiliary Embolization Material
    • 1.3.8 Others
  • 1.4 Global Embolotherapy Market by Application
    • 1.4.1 Overview: Global Embolotherapy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Cancer
    • 1.4.3 Peripheral Aascular Disease
    • 1.4.4 Nerve System Disease
    • 1.4.5 Others
  • 1.5 Global Embolotherapy Market Size & Forecast
  • 1.6 Global Embolotherapy Market Size and Forecast by Region
    • 1.6.1 Global Embolotherapy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Embolotherapy Market Size by Region, (2019-2030)
    • 1.6.3 North America Embolotherapy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Embolotherapy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Embolotherapy Market Size and Prospect (2019-2030)
    • 1.6.6 South America Embolotherapy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Embolotherapy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Embolotherapy Product and Solutions
    • 2.1.4 Medtronic Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Medtronic Recent Developments and Future Plans
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Embolotherapy Product and Solutions
    • 2.2.4 Boston Scientific Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Boston Scientific Recent Developments and Future Plans
  • 2.3 Terumo
    • 2.3.1 Terumo Details
    • 2.3.2 Terumo Major Business
    • 2.3.3 Terumo Embolotherapy Product and Solutions
    • 2.3.4 Terumo Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Terumo Recent Developments and Future Plans
  • 2.4 Penumbra, Inc.
    • 2.4.1 Penumbra, Inc. Details
    • 2.4.2 Penumbra, Inc. Major Business
    • 2.4.3 Penumbra, Inc. Embolotherapy Product and Solutions
    • 2.4.4 Penumbra, Inc. Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Penumbra, Inc. Recent Developments and Future Plans
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Embolotherapy Product and Solutions
    • 2.5.4 Johnson & Johnson Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.6 Sirtex
    • 2.6.1 Sirtex Details
    • 2.6.2 Sirtex Major Business
    • 2.6.3 Sirtex Embolotherapy Product and Solutions
    • 2.6.4 Sirtex Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sirtex Recent Developments and Future Plans
  • 2.7 Merit Medical
    • 2.7.1 Merit Medical Details
    • 2.7.2 Merit Medical Major Business
    • 2.7.3 Merit Medical Embolotherapy Product and Solutions
    • 2.7.4 Merit Medical Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Merit Medical Recent Developments and Future Plans
  • 2.8 Varian
    • 2.8.1 Varian Details
    • 2.8.2 Varian Major Business
    • 2.8.3 Varian Embolotherapy Product and Solutions
    • 2.8.4 Varian Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Varian Recent Developments and Future Plans
  • 2.9 Stryker
    • 2.9.1 Stryker Details
    • 2.9.2 Stryker Major Business
    • 2.9.3 Stryker Embolotherapy Product and Solutions
    • 2.9.4 Stryker Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Stryker Recent Developments and Future Plans
  • 2.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
    • 2.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
    • 2.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
    • 2.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product and Solutions
    • 2.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments and Future Plans
  • 2.11 Cook Medical
    • 2.11.1 Cook Medical Details
    • 2.11.2 Cook Medical Major Business
    • 2.11.3 Cook Medical Embolotherapy Product and Solutions
    • 2.11.4 Cook Medical Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Cook Medical Recent Developments and Future Plans
  • 2.12 Kaneka
    • 2.12.1 Kaneka Details
    • 2.12.2 Kaneka Major Business
    • 2.12.3 Kaneka Embolotherapy Product and Solutions
    • 2.12.4 Kaneka Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Kaneka Recent Developments and Future Plans
  • 2.13 Meril Life Sciences
    • 2.13.1 Meril Life Sciences Details
    • 2.13.2 Meril Life Sciences Major Business
    • 2.13.3 Meril Life Sciences Embolotherapy Product and Solutions
    • 2.13.4 Meril Life Sciences Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Meril Life Sciences Recent Developments and Future Plans
  • 2.14 Peijia Medical Limited
    • 2.14.1 Peijia Medical Limited Details
    • 2.14.2 Peijia Medical Limited Major Business
    • 2.14.3 Peijia Medical Limited Embolotherapy Product and Solutions
    • 2.14.4 Peijia Medical Limited Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Peijia Medical Limited Recent Developments and Future Plans
  • 2.15 Wallaby Medical
    • 2.15.1 Wallaby Medical Details
    • 2.15.2 Wallaby Medical Major Business
    • 2.15.3 Wallaby Medical Embolotherapy Product and Solutions
    • 2.15.4 Wallaby Medical Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Wallaby Medical Recent Developments and Future Plans
  • 2.16 MicroPort Scientific Corporation
    • 2.16.1 MicroPort Scientific Corporation Details
    • 2.16.2 MicroPort Scientific Corporation Major Business
    • 2.16.3 MicroPort Scientific Corporation Embolotherapy Product and Solutions
    • 2.16.4 MicroPort Scientific Corporation Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 MicroPort Scientific Corporation Recent Developments and Future Plans
  • 2.17 Shandong Visee Medical Devices Co.,Ltd
    • 2.17.1 Shandong Visee Medical Devices Co.,Ltd Details
    • 2.17.2 Shandong Visee Medical Devices Co.,Ltd Major Business
    • 2.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product and Solutions
    • 2.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments and Future Plans
  • 2.18 Beijing Taijie Weiye Technology
    • 2.18.1 Beijing Taijie Weiye Technology Details
    • 2.18.2 Beijing Taijie Weiye Technology Major Business
    • 2.18.3 Beijing Taijie Weiye Technology Embolotherapy Product and Solutions
    • 2.18.4 Beijing Taijie Weiye Technology Embolotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Beijing Taijie Weiye Technology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Embolotherapy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Embolotherapy by Company Revenue
    • 3.2.2 Top 3 Embolotherapy Players Market Share in 2023
    • 3.2.3 Top 6 Embolotherapy Players Market Share in 2023
  • 3.3 Embolotherapy Market: Overall Company Footprint Analysis
    • 3.3.1 Embolotherapy Market: Region Footprint
    • 3.3.2 Embolotherapy Market: Company Product Type Footprint
    • 3.3.3 Embolotherapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Embolotherapy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Embolotherapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Embolotherapy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Embolotherapy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Embolotherapy Consumption Value by Type (2019-2030)
  • 6.2 North America Embolotherapy Market Size by Application (2019-2030)
  • 6.3 North America Embolotherapy Market Size by Country
    • 6.3.1 North America Embolotherapy Consumption Value by Country (2019-2030)
    • 6.3.2 United States Embolotherapy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Embolotherapy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Embolotherapy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Embolotherapy Consumption Value by Type (2019-2030)
  • 7.2 Europe Embolotherapy Consumption Value by Application (2019-2030)
  • 7.3 Europe Embolotherapy Market Size by Country
    • 7.3.1 Europe Embolotherapy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Embolotherapy Market Size and Forecast (2019-2030)
    • 7.3.3 France Embolotherapy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Embolotherapy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Embolotherapy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Embolotherapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Embolotherapy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Embolotherapy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Embolotherapy Market Size by Region
    • 8.3.1 Asia-Pacific Embolotherapy Consumption Value by Region (2019-2030)
    • 8.3.2 China Embolotherapy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Embolotherapy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Embolotherapy Market Size and Forecast (2019-2030)
    • 8.3.5 India Embolotherapy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Embolotherapy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Embolotherapy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Embolotherapy Consumption Value by Type (2019-2030)
  • 9.2 South America Embolotherapy Consumption Value by Application (2019-2030)
  • 9.3 South America Embolotherapy Market Size by Country
    • 9.3.1 South America Embolotherapy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Embolotherapy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Embolotherapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Embolotherapy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Embolotherapy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Embolotherapy Market Size by Country
    • 10.3.1 Middle East & Africa Embolotherapy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Embolotherapy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Embolotherapy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Embolotherapy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Embolotherapy Market Drivers
  • 11.2 Embolotherapy Market Restraints
  • 11.3 Embolotherapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Embolotherapy Industry Chain
  • 12.2 Embolotherapy Upstream Analysis
  • 12.3 Embolotherapy Midstream Analysis
  • 12.4 Embolotherapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Embolotherapy market size was valued at US$ 4216 million in 2023 and is forecast to a readjusted size of USD 6663 million by 2030 with a CAGR of 6.8% during review period.
    Global key players of Embolotherapy include Medtronic, Boston Scientific, etc. Global top 3 companies hold a share over 30%. North America is the largest market, with a share about 35%, followed by Europe and China with the share about 25% and 20%. In terms of product, Microspheres for Embolization is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer, with a share about 50%.
    This report is a detailed and comprehensive analysis for global Embolotherapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Embolotherapy market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Embolotherapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Embolotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Embolotherapy market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Embolotherapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Embolotherapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian, Stryker, Jiangsu Hengrui Pharmaceuticals Co., Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Embolotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Embolotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Microspheres for Embolization
    Embolism Particles
    Embolic coils
    Liquid Embolic Agent
    Auxiliary Embolization Material
    Others
    Market segment by Application
    Cancer
    Peripheral Aascular Disease
    Nerve System Disease
    Others
    Market segment by players, this report covers
    Medtronic
    Boston Scientific
    Terumo
    Penumbra, Inc.
    Johnson & Johnson
    Sirtex
    Merit Medical
    Varian
    Stryker
    Jiangsu Hengrui Pharmaceuticals Co., Ltd
    Cook Medical
    Kaneka
    Meril Life Sciences
    Peijia Medical Limited
    Wallaby Medical
    MicroPort Scientific Corporation
    Shandong Visee Medical Devices Co.,Ltd
    Beijing Taijie Weiye Technology
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Embolotherapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Embolotherapy, with revenue, gross margin, and global market share of Embolotherapy from 2019 to 2024.
    Chapter 3, the Embolotherapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Embolotherapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Embolotherapy.
    Chapter 13, to describe Embolotherapy research findings and conclusion.

    Buy now